Saturday, November 18, 2017

Opinion / DT 6 / 2008

Questioning the 1.5 billion dollar vaccine deal

Médecins Sans Frontières does not deny the rationale of the Advance Market Commitment: a new vaccine against pneumococcal disease is desperately needed. Over a million people, mostly children, die each year of pneumonia, bloodstream infections and meningitis caused by pneumococcal bacteria. But why is it so expensive?
Tido von Schoenangerer

Tido von Schoenangerer, Director of Campaign for Essential Medicines at MSF.
Photo by Sebastian Bolesch

 

 

Development Today is a subscription-based online journal. To subscribe click here.

If you are already a subscriber to Development Today please log in.

Would you like to know more about Development Today? Click here.